CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Product NDC
- 49527-080
- 11-digit product format
- 495270080
- Labeler code
- 49527
- Product ID
- 49527-080_0818396d-cc21-00ac-e063-6394a90a5d82
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- TITANIUM DIOXIDE, ZINC OXIDE
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- CLINIQUE LABORATORIES LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-09-24
- Substance
- TITANIUM DIOXIDE; ZINC OXIDE
- Active strength
- 24; 59 mg/mL; mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 49527-080 | 49527-080-03 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f764e8902f78… | 92046438deef… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… | |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… | |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TITANIUM DIOXIDE | 24 mg/mL |
| ZINC OXIDE | 59 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 15FIX9V2JP | Internal UNII lookup |
| SOI2LOH54Z | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 884abba1-891d-4c3c-b203-38a5a8a57756 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 30 mL in 1 BOTTLE | LIQUID | 30 | 13 | |
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 5 mL in 1 TUBE | LIQUID | 5 | 13 | |
| 49527-080-03 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 0.2 mL in 1 PACKET | LIQUID | 0.2 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49527-080 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 (TITANIUM DIOXIDE, ZINC OXIDE) LIQUID [CLINIQUE LABORATORIES LLC] | 13 | Current NDC, Legacy NDC, 5 package rows | 20231020_884abba1-891d-4c3c-b203-38a5a8a57756.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Avebonzone, Homosalate, Octisalate | AVEBONZONE, HOMOSALATE, OCTISALATE | Amazon.com Services LLC | 4ab66c16-5f4c-6987-e063-6294a90add86 | 2026-02-26 | Warnings, Adverse reactions | M020 |
| Seonglow Daily Moisturizing Sunscreen SPF 50 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | SeonGlow Inc. | 01f3479f-3a0d-420b-bbf8-62a0a225bc9b | 2026-02-26 | Warnings | M020 |
| Avebonzone, Homosalate, Octisalate | AVEBONZONE, HOMOSALATE, OCTISALATE | Amazon.com Services LLC | 4ab5d5ca-26bf-1c5f-e063-6394a90a00ca | 2026-02-26 | Warnings, Adverse reactions | M020 |
| SPF50 Moisturizer with Aloe, Green Tea and Shea Butter | ZINC OXIDE | Audrey Morris Cosmetics International, LLC | 92960e14-9845-49aa-b3ce-c8023aa109b6 | 2026-02-26 | Warnings | M020 |
| Naturalessa SPF50 Moisturizer | ZINC OXIDE | Audrey Morris Cosmetics International, LLC | 816ddfa1-cb55-4591-a90b-71631cb17626 | 2026-02-26 | Warnings | M020 |
| UV DEFENSE FACE MINERAL SPF 50 | ZINC OXIDE | BETTER INVENTION LTD | 4b9a9efe-9aba-0ed0-e063-6394a90a2c6b | 2026-02-26 | Warnings | M020 |
| MISTINE UV DEFENSE FACE SUNSCREEN SPF50 | AVOBENZONE, HOMOSOLATE, OCTISALATE, OCTOCRYLENE | BETTER INVENTION LTD | 4b9a8f28-9043-8fb7-e063-6294a90a34d3 | 2026-02-26 | Warnings | M020 |
| MISTINE UV INVISIBLE FACE SHEER SUNSCREEN SPF 50 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | BETTER INVENTION LTD | 4b9a8f28-9041-8fb7-e063-6294a90a34d3 | 2026-02-26 | Warnings | M020 |
| Rationale The Discovery Travel Kit | ZINC OXIDE | RATIONALE GROUP PTY LTD | 0c919aea-4bd4-427e-97e7-9c153b42f491 | 2026-02-25 | Warnings | M020 |
| Kiss My Face Purely Mineral Daily 50 Sunscreen SPF 50 | ZINC OXIDE | Windmill Health Products, LLC | ebfb149c-0371-4492-b03a-5fdcb7821753 | 2026-02-25 | Warnings | M020 |
| SHISEIDO UV PROTECTIVE COMPACT (REFILL) FAIR IVORY | OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | c05cef12-a6a7-4682-9357-6d77f4ca3267 | 2026-02-25 | Warnings | M020 |
| cle de peau BEAUTE Protective Day | AVOBENZONE, OCTINOXATE, OCTOCRYLENE | Shiseido Americas Corporation | dea8e4c1-6a9c-44c6-abc8-6cdd50f35f49 | 2026-02-25 | Warnings | M020 |
| Aura Defense | ZINC OXIDE | Grace and Glow MD LLC | 4ba75eff-74ef-278b-e063-6394a90a8ef0 | 2026-02-25 | Warnings | M020 |
| AM Shield plus | ZINC OXIDE | Grace and Glow MD LLC | 4ba7c282-c68e-8719-e063-6394a90a3814 | 2026-02-25 | Warnings | M020 |
| cle de peau BEAUTE RADIANT FOUNDATION N M I10 | OCTINOXATE AND TITANIUM DIOXIDE | Shiseido Americas Corporation | 3be1fe06-bd3b-4078-bee9-d3caf8d068ff | 2026-02-25 | Warnings | M020 |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4babe2ab-c5da-9a83-e063-6294a90aee4c | 2026-02-25 | Warnings | M020 |
| Daily Facial Moisturizer SPF 25 | SUNSCREEN | Person and Covey | 6b9258e4-c7c6-765e-e053-2991aa0a9f4e | 2026-02-25 | Warnings | M020 |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4bac1c33-36fe-8d29-e063-6394a90a32a5 | 2026-02-25 | Warnings | M020 |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4bac5550-c45f-a738-e063-6394a90ae5c8 | 2026-02-25 | Warnings | M020 |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4baca374-7aaa-8d1d-e063-6394a90a5a55 | 2026-02-25 | Warnings | M020 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49527-080-01 | 49527008001 | 1 BOTTLE in 1 CARTON (49527-080-01) / 30 mL in 1 BOTTLE | 1 bottle | 2020-09-24 | 0000-00-00 | No | No | Current |
| 49527-080-02 | 49527008002 | 1 TUBE in 1 CARTON (49527-080-02) / 5 mL in 1 TUBE | 1 tube | 2022-06-06 | 0000-00-00 | No | No | Current |
| 49527-080-03 | 49527008003 | .2 mL in 1 PACKET (49527-080-03) | 2022-11-30 | 0000-00-00 | Yes | No | Current |